Counselors in Watkins, CO Accepting Medicare
7 Counselors found. Showing 1 - 7
 Gwen Prouty, LPC, CAC111 Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 28101 E Quincy Ave, Watkins, CO 80137 Phone: 303-766-3000 |
 James Snyder Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 28101 E Quincy Ave., Watkins, CO 80137 Phone: 720-934-9129 |
Zachary Gaiter Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2801 E. Quincy Ave, Watkins, CO 80137 Phone: 303-766-3000 |
Ms. Whitney Carrin Harrah, LPC, CACIII, MAC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 325 S Almstead Rd, Watkins, CO 80137 Phone: 720-484-4996 Fax: 720-484-4993 |
Jacilyn Berryman Counselor - School Medicare: Not Enrolled in Medicare Practice Location: 28101 E Quincy Ave, Watkins, CO 80137 Phone: 303-766-3000 |
Laura Schniedwind, MA, NCC, LPCC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 28101 E Quincy Ave, Watkins, CO 80137 Phone: 303-214-1165 |
Ms. Karen Elizabeth Brandon Robinson, M.S., LPC, NCC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 325 S Almstead Rd, Watkins, CO 80137 Phone: 720-487-9892 |
News Archive
Relationship between the CD14 variation and the formation of portal lymphoid aggregates discovered
It is still unknown why the natural history of chronic disease caused by hepatitis C virus (HCV), which currently infects 3% of the world's population, varies from mild in some patients to rapidly progressing in others. Age, sex, alcohol consumption and liver sensitivity to gut-derived bacterial endotoxins, were the early factors defined to enhance the risk of fibrosis progression.
Arthritis drug baricitinib meets primary endpoint in Phase 3 RA-BEACON study
Eli Lilly and Company and Incyte Corporation today announce that the Phase 3 RA-BEACON study of the investigational medicine baricitinib met its primary endpoint of improved ACR20 response compared to placebo after 12 weeks of treatment.
Study reveals increased incidence of major adverse cardiac events in patients with severe psoriasis
Psoriasis is a common inflammatory skin disease, and if severe, has been demonstrated to be a risk factor for cardiovascular (CV) disease. However, the degree to which psoriasis is associated with major adverse cardiac events (MACE), such as heart attack, stroke, and cardiovascular death has not been defined. Now, new research from the University of Pennsylvania School of Medicine has revealed an increased incidence of MACE in patients with severe psoriasis.
Kalorama's new report on global advanced patient monitoring market
According to Kalorama Information, the global advanced patient monitoring market is currently worth about $31.4 billion, inclusive of devices, peripherals, software, packaged services and other applications. The market has benefited from the demand to move to a more wireless and streamlined operation both within major health facilities and in the home treatment markets.
› Verified 9 days ago